Pharma Stock Recommends Dividend Of ₹30. Details Here | Mint - Mint

Divis Labs said that the record date for the purpose of the payment of dividend will be informed in due course

While announcing its Q4FY22 earnings, Divi's Laboratories said that its board has recommended a dividend of 30 for the financial year 2021-22. Shares of Divi's Labs were trading about a per cent high… [+1134 chars]

full article...